Stryker Corporation
SYK
株式のランク
#196
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
株価
$297.81
時価総額
$114.23B
変化（1日）
-2.27%
変化（1年）
-21.58%
国
US
取引 Stryker Corporation (SYK)
カテゴリー
Healthcare
Stryker Corporation（SYK）の収益
Jun 2026 時点の収益 TTM: $25.84B
Stryker Corporation の最新の財務報告によると、現在の収益 (TTM) は $25.84B です。2024 年には $22.60B の収益があり、これは 2023 年の $20.50B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Stryker Corporation の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $25.84B | 2.87% |
| 2025 | $25.12B | 11.16% |
| 2024 | $22.60B | 10.23% |
| 2023 | $20.50B | 11.11% |
| 2022 | $18.45B | 7.84% |
| 2021 | $17.11B | 19.21% |
| 2020 | $14.35B | -3.58% |
| 2019 | $14.88B | 9.43% |
| 2018 | $13.60B | 9.30% |
| 2017 | $12.44B | 9.88% |
| 2016 | $11.33B | 13.86% |
| 2015 | $9.95B | 2.80% |
| 2014 | $9.68B | 7.25% |
| 2013 | $9.02B | 4.20% |
| 2012 | $8.66B | 4.21% |
| 2011 | $8.31B | 13.48% |
| 2010 | $7.32B | 8.88% |
| 2009 | $6.72B | 0.07% |
| 2008 | $6.72B | 11.96% |
| 2007 | $6.00B | 11.01% |
| 2006 | $5.41B | 10.96% |
| 2005 | $4.87B | 14.29% |
| 2004 | $4.26B | 17.57% |
| 2003 | $3.63B | 20.38% |
| 2002 | $3.01B | 15.73% |
| 2001 | $2.60B | 13.67% |
| 2000 | $2.29B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 80.30% |
US
|
|
| $35.48B | 37.34% |
IE
|
|
| $21.00B | -18.74% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -74.79% |
US
|
